J Breast Cancer.  2006 Jun;9(2):74-83. 10.4048/jbc.2006.9.2.74.

Validation and Controversy of Sentinel Node Biopsy for Breast Cancer

• Motomura K
• Egawa C
• Komoike Y
• Kataoka T
• Nagumo S
• Koyama H
• Inaji H

• KMID: 2286623
• DOI: http://doi.org/10.4048/jbc.2006.9.2.74

Abstract

Sentinel node biopsy has become a promising technique to accurately stage breast cancer patients with less morbidity than axillary lymph node dissection. However, many problems remain, such as the ideal injection technique, agents, and histological detection of sentinel node metastases, and they must be addressed before sentinel node biopsy becomes the standard for the care of breast cancer patients. The results of ongoing large clinical trials will provide clues to solve these problems. The purpose of this article is to review the current literature regarding confirmation of the sentinel node hypothesis and the controversy of sentinel node biopsy.

Keyword

sentinel node; breast cancer; sentinel node biopsy

MeSH Terms

Biopsy*
Breast Neoplasms*
Breast*
Humans
Lymph Node Excision
Neoplasm Metastasis

Reference

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994. 220:391–401.

2. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997. 15:2345–2350.

3. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, et al. Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodes. Breast Cancer. 1999. 6:259–262.

4. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer:A multicenter validation study. N Engl J Med. 1998. 339:941–946.

5. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997. 349:1864–1867.

6. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996. 276:1818–1822.

7. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer. J Surg Oncol. 2001. 76:95–99.

8. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000. 18:2553–2559.

9. Roumen RM, Kuijt GP, Liem IH, van Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg. 2001. 88:1639–1643.

10. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004. 240:462–468.

11. Motomura K, Egawa C, Komoike Y, Hasegawa Y, Koyama H, Inaji H. Axillary recurrence after negative sentinel node biopsy in a patient with breast cancer: report of a case. Surg Today. 2006. 36:267–269.

12. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003. 349:546–553.

13. Julian TB, Krag D, Brown A, et al. A randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. Breast cancer Res Treat. 2004. suppl 19:abstract #140.

14. A prognostic study of sentinel node and bone marrow micrometastases in women with clinical T1 or T2 N0 M0 breast cancer. American College of Surgeons Oncology Group. accessed Apr 21, 2006. https://www.acosog.org/studies/synopses/Z0010_Synopsis.pdf.

15. Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield L, et al. ALMANAC Trialists Group. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer. 2005. 41:238–243.

16. Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, et al. Learning sentinel node biopsy:Results of a prospective randomized trial of two techniques. Surgery. 1999. 126:714–722.

17. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000. 18:2560–2566.

18. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005. 23:7703–7720.

19. Consensus Statement on Guidelines for Performing Sentinel Lymph Node Dissection in Breast Cancer. The American Society of Breast Surgeons. accessed Apr 21, 2006. http://www.breastsurgeons.org/slnd.shtml.

20. Nieweg O. Lymphatics of the breast and the rationale for different injection techniques. Ann Surg Oncol. 2001. 8:71S–73S.

21. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001. 233:676–687.

22. Chagpar A, Martin RC 3rd, Chao C, Wong SL, Edwards MJ, Tuttle T, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg. 2004. 139:614–618.

23. Motomura K, Komoike Y, Hasegawa Y, Kasugai T, Inaji H, Noguchi S, et al. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients. J Surg Oncol. 2003. 82:91–96.

24. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Hasegawa Y, et al. Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients. Eur J Surg Oncol. 2001. 27:141–145.

25. Flett MM, Going JJ, Station PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg. 1998. 85:991–993.

26. van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. 1999. 35:14–18.

27. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol. 1998. 5:689–694.

28. Weiser MR, Montgomery LL, Susnik B, Tan LK, Borgen PI, Cody HS. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile. Ann Surg Oncol. 2000. 7:651–655.

29. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst. 1999. 91:368–373.

30. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997. 349:1864–1867.

31. McCready DR. Intraoperative sentinel node assessment is a touchy subject. Ann Surg Oncol. 2002. 9:321–323.

32. Henry-Tillman RS, Korourian S, Rubio IT, Johnson AT, Mancino AT, Massol N, et al. Intraoperative touch preparation for sentinel lymph node biopsy:α 4-year experience. Ann Surg Oncol. 2002. 9:333–339.

33. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg. 2000. 87:597–601.

34. Motomura K, Noguchi A, Hashizume T, Hasegawa Y, Komoike Y, Inaji H, et al. Usefulness of a solid-state gamma camera for sentinel node identification in patients with breast cancer. J Surg Oncol. 2005. 89:12–17.

35. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE, et al. Do all patients with sentinel node metastasis from breat carcinoma need complete axillary node dissection? Ann Surg. 1999. 229:536–541.

36. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, et al. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999. 17:1720–1726.

37. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005. 241:319–325.

38. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer. 2003. 98:2307–2315.

39. Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004. 91:1245–1252.

40. Motomura K, EgawaC , Komoike Y, Hasegawa Y, Koyama H, Inaji H, et al. Three axillary lymph node sampling for the prediction of non-sentinel node metastases in breast cancer patients with sentinel node metastases. Ann Surg Oncol. 2000. (in press).

41. International (Ludwig) breast cancer study group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet. 1990. 335:1565–1568.

42. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer. 1999. 86:990–996.

43. Motomura K, Komoike Y, Inaji Y, Hasegawa Y, Kasugai T, Noguchi S, et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg. 2002. 89:1032–1034.